Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Tennessee by County

Non-Hodgkin Lymphoma (Late Stage^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


Tennessee6


US (SEER+NPCR)1


Madison County6


Carter County6


Henderson County6


Lincoln County6


Coffee County6


Gibson County6


Cumberland County6


Bedford County6


Dyer County6


Claiborne County6


Weakley County6


Henry County6


McNairy County6


Shelby County6


Bradley County6


Jefferson County6


Davidson County6


Montgomery County6


Carroll County6


Hamilton County6


Marion County6


Wilson County6


Blount County6


Cocke County6


Giles County6


Monroe County6


Sevier County6


Cheatham County6


Dickson County6


Morgan County6


McMinn County6


Knox County6


Fayette County6


Hamblen County6


Hardeman County6


Sumner County6


Robertson County6


Washington County6


Campbell County6


Greene County6


Marshall County6


DeKalb County6


Tipton County6


Roane County6


Franklin County6


Rutherford County6


White County6


Putnam County6


Smith County6


Loudon County6


Sullivan County6


Lawrence County6


Union County6


Hawkins County6


Grainger County6


Maury County6


Williamson County6


Anderson County6


Polk County6


Scott County6


Wayne County6


Macon County6


Humphreys County6


Warren County6


Hickman County6


Rhea County6


Benton County6 Bledsoe County6 Cannon County6 Chester County6 Clay County6 Crockett County6 Decatur County6 Fentress County6 Grundy County6 Hancock County6 Hardin County6 Haywood County6 Houston County6 Jackson County6 Johnson County6 Lake County6 Lauderdale County6 Lewis County6 Meigs County6 Moore County6 Obion County6 Overton County6 Perry County6 Pickett County6 Sequatchie County6 Stewart County6 Trousdale County6 Unicoi County6 Van Buren County6

Notes:
Created by statecancerprofiles.cancer.gov on 03/28/2024 1:21 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.